Off-label use of drugs in children

Frattarelli, D. A.; Galinkin, J. L.; Green, T. P.; Johnson, T. D.; Neville, K. A.; Paul, I. M.; Van Den Anker, J. N.

Pediatrics. 2014 Feb 26; 133(3):563-7


The passage of the Best Pharmaceuticals for Children Act and the Pediatric Research Equity Act has collectively resulted in an improvement in rational prescribing for children, including more than 500 labeling changes. However, off-label drug use remains an important public health issue for infants, children, and adolescents, because an overwhelming number of drugs still have no information in the labeling for use in pediatrics. The purpose of off-label use is to benefit the individual patient. Practitioners use their professional judgment to determine these uses. As such, the term "off-label" does not imply an improper, illegal, contraindicated, or investigational use. Therapeutic decision-making must always rely on the best available evidence and the importance of the benefit for the individual patient.

Read More on PubMed